,Chapter 01: Information Sources, Regulatory Agencies, D g Legislation, and Prescription Writing
ji ji ji ji ji ji ji ji ji ji ji
Haveles: Applied Pharmacology for the Dental Hygienist, 9th Edition
ji ji ji ji ji ji ji ji
MULTIPLE CHOICE ji
1. Knowledge of pharmacology aids the dental professional in ji ji ji ji ji ji ji
a. obtaining a patient’s health history. ji ji ji ji
b. administering d gs in the office. ji ji ji ji ji
c. handling emergency situations. ji ji
d. selection of a nonprescription medication. ji ji ji ji
e. All of the above. ji ji ji
ANS: E j i
All of the choices are t e. Because many of our patients are being treated with d gs, knowledge of pharma
ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji
cology helps in understanding and interpreting patients’ responses to health history questions. Knowledg
ji ji ji ji ji ji ji ji ji ji ji ji
e of the therapeutic and adverse effects of medications obviously helps in their proper administration in t
ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji
he office. Emergency situations may be caused by d gs or treated by d gs; thus, knowledge of pharmacol
ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji
ogy is of great help, especially because a rapid response is sometimes required. A clear understanding of
ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji j
the concepts of d g action, d g handling by the body, and d g interactions will allow the dental practitione
i ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji
r to make proper judgments and grasp the concepts relevant to new d g therapies on the market.
ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji
DIF: Application
REF: Role of the Dental Hygienist (Medication/Health History), Role of the Dental Hygienist (Medication
j i ji ji ji ji ji ji ji ji ji ji ji ji ji
Administration), Role of the Dental Hygienist (Emergency Situations), Role of the Dental Hygienist (Nonpre ji ji ji ji ji ji ji ji ji ji ji ji ji
scription Medication) | pp. 2-3 ji OBJ: 1 ji ji ji
TOP: NBDHE, 6.0. Pharmacology
j i ji ji
2. Which of the following statements is t e regarding planning appointments?
ji ji ji ji ji ji ji ji ji ji
a. Whether or not patients are taking medication for systemic diseases is of little
ji ji ji ji ji ji ji ji ji ji ji ji
consequence in the dental office. ji ji ji ji
b. Asthmatic patients should have dental appointments in the morning. ji ji ji ji ji ji ji ji
c. Diabetic patients usually have fewer problems with a morning appointment com
ji ji ji ji ji ji ji ji ji ji
pared with afternoon appointments. ji ji ji
d. Both B and C are t e. ji ji ji ji ji ji
ANS: D j i
Asthmatic patients who experience dental anxiety should schedule their appointments when they are not
ji ji ji ji ji ji ji ji ji ji ji ji ji jij
shed or under pressure early in the morning. Diabetic patients usually have relatively fewer problems wi
i ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji
th a morning appointment. Patients taking medication for systemic diseases may require special handlin
ji ji ji ji ji ji ji ji ji ji ji ji ji
g in the dental office.
ji ji ji ji
DIF: Comprehension
REF: Role of the Dental Hygienist (Appointment Scheduling) | p. 3
j i ji ji ji ji ji ji ji ji ji ji
OBJ: 1 TOP: NBDHE, 6.0. Pharmacology
j i j i ji ji
,3. Nutritional or herbal supplements ji ji ji
a. carry the U.S. Food and D g Administration (FDA) approval for disease states.
ji ji ji ji ji ji ji ji ji ji ji ji
b. are not d gs. ji ji ji
c. can cause adverse effects. ji ji ji
d. will not interact with other d gs the patient may be taking.
ji ji ji ji ji ji ji ji ji ji ji
ANS: C j i
Nutritional or herbal supplements are quite capable of causing adverse effects. The majority of nutritional
ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji
or herbal supplements do not carry FDA approval for treating disease states. These supplements are d gs a
ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji
nd can cause adverse effects and interact with different d gs.
ji ji ji ji ji ji ji ji ji ji
DIF: Comprehension
REF: Role of the Dental Hygienist (Nutritional or Herbal Supplements) | p. 3
j i ji ji ji ji ji ji ji ji ji ji ji ji
OBJ: 1 TOP: NBDHE, 6.0. Pharmacology
j i j i ji ji
4. Which type of d g name usually begins with a lowercase letter?
ji ji ji ji ji ji ji ji ji ji ji
a. Brand name ji
b. Code name ji
c. Generic name ji
d. Trade name ji
ANS: C j i
Before any d g is marketed, it is given a generic name that becomes the ―official‖ name of the d g. Each d
ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji
g is assigned only one generic name selected by the U.S. Adopted Name Council, and the name is not ca
ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji
pitalized. The brand name is equivalent to the trade name and is capitalized. Although the brand name is
ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji
technically the name of the company marketing the product, this term is often used interchangeably with
ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji
the trade name. The code name is the initial term used within a pharmaceutical company to refer to a d g
ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji
while it is undergoing investigation and is often a combination of capital letters and numbers, the letters
ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji
representing an abbreviation of the company name. ji ji ji ji ji ji
DIF: Comprehension
REF: D g Names | p. 4 OBJ: 3 j i ji ji ji ji ji ji j i
TOP: NBDHE, 6.0. Pharmacology j i ji ji
5. A d g’s generic name is selected by the
ji ji ji ji ji ji ji ji
a. pharmaceutical company manufacturing it. ji ji ji
b. Food and D g Administration (FDA). ji ji ji ji ji
c. U.S. Adopted Name Council. ji ji ji
d. Federal Patent Office. ji ji
ANS: C j i
Each d g is assigned only one generic name (e.g., ibuprofen). It is selected by the U.S. Adopted Name C
ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji
ouncil. The generic name is not selected by the FDA or the Federal Patent Office. The pharmaceutical c
ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji
ompany manufacturing the d g clearly has an influence on the generic name given its d g, but the final dec
ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji
ision is not the company’s.
ji ji ji ji
DIF: Recall REF: D g Names | p. 4 j i ji ji ji ji ji
OBJ: 3 TOP: NBDHE, 6.0. Pharmacology j i ji j i ji ji
6. Which of the following is t e concerning generic and trade names of d gs?
ji ji ji ji ji ji ji ji ji ji ji ji ji ji
a. A d g may only have one generic name and one trade name.
ji ji ji ji ji ji ji ji ji ji ji ji
, b. A d g may only have one generic name, but it may have several trade names.
ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji
c. A d g may have several generic names, but it may only have one trade name.
ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji
d. A d g may have several generic names and several trade names.
ji ji ji ji ji ji ji ji ji ji ji
ANS: B j i
Each d g has only one generic name but may have several trade names. For each d g, there is only one ge
ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji
neric name. It is not capitalized, and it becomes the ―official‖ name of the d g. The pharmaceutical comp
ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji
any discovering the d g gives the d g a trade name. The trade name is protected by the Federal Patent Law
ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji j
for 20 years from the earliest claimed filing date, plus patent term extensions. Although the brand name i
i ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji
s technically the name of the company marketing the product, it is often used interchangeably with the tra
ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji
de name. ji
DIF: Comprehension
REF: D g Names | p. 4 OBJ: 3 j i ji ji ji ji ji ji j i
TOP: NBDHE, 6.0. Pharmacology j i ji ji
7. Two d gs that are found to be chemically equivalent, but not biologically equivalent or ther
ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji
apeutically equivalent are said to differ in ji ji ji ji ji ji
a. potency.
b. efficacy.
c. bioavailability.
d. therapeutic index. ji
ANS: C j i
A preparation can be chemically equivalent yet not biologically or therapeutically equivalent. These pro
ji ji ji ji ji ji ji ji ji ji ji ji ji
ducts are said to differ in their bioavailability. The potency of a d g is a function of the amount of d g requi
ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji
red to produce an effect. The efficacy is the maximum intensity of effect or response that can be produce
ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji
d by a d g. The therapeutic index is the ratio of the lethal dose for 50% of the experimental animals divid
ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji
ed by the effective dose for 50% of the experimental animals. If the value of the therapeutic index is sma
ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji
ll, toxicity is more likely.
ji ji ji ji
DIF: Recall
REF: D g Names (D g Substitution) | p. 5 OBJ: 4
j i ji ji ji ji ji ji ji ji ji j i
TOP: NBDHE, 6.0. Pharmacology j i ji ji
8. How many years must pass after a d g patent expires before other d g companies can market the same
ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji
compound as a generic d g? ji ji ji ji ji
a. 20 years ji
b. 17 years ji
c. 7 years ji
d. 0 years ji
ANS: D j i
Once a d g patent expires, competing companies may immediately market the same compound in generi
ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji
c form. The pharmaceutical company discovering the d g gives the d g a trade name. The trade name is pr
ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji
otected by the Federal Patent Law for 20 years from the earliest claimed filing date, plus the patent term e
ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji
xtensions.
DIF: Application
REF: D g Names (D g Substitution) | p. 5 OBJ: 4
j i ji ji ji ji ji ji ji ji ji j i
TOP: NBDHE, 6.0. Pharmacology j i ji ji
ji ji ji ji ji ji ji ji ji ji ji
Haveles: Applied Pharmacology for the Dental Hygienist, 9th Edition
ji ji ji ji ji ji ji ji
MULTIPLE CHOICE ji
1. Knowledge of pharmacology aids the dental professional in ji ji ji ji ji ji ji
a. obtaining a patient’s health history. ji ji ji ji
b. administering d gs in the office. ji ji ji ji ji
c. handling emergency situations. ji ji
d. selection of a nonprescription medication. ji ji ji ji
e. All of the above. ji ji ji
ANS: E j i
All of the choices are t e. Because many of our patients are being treated with d gs, knowledge of pharma
ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji
cology helps in understanding and interpreting patients’ responses to health history questions. Knowledg
ji ji ji ji ji ji ji ji ji ji ji ji
e of the therapeutic and adverse effects of medications obviously helps in their proper administration in t
ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji
he office. Emergency situations may be caused by d gs or treated by d gs; thus, knowledge of pharmacol
ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji
ogy is of great help, especially because a rapid response is sometimes required. A clear understanding of
ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji j
the concepts of d g action, d g handling by the body, and d g interactions will allow the dental practitione
i ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji
r to make proper judgments and grasp the concepts relevant to new d g therapies on the market.
ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji
DIF: Application
REF: Role of the Dental Hygienist (Medication/Health History), Role of the Dental Hygienist (Medication
j i ji ji ji ji ji ji ji ji ji ji ji ji ji
Administration), Role of the Dental Hygienist (Emergency Situations), Role of the Dental Hygienist (Nonpre ji ji ji ji ji ji ji ji ji ji ji ji ji
scription Medication) | pp. 2-3 ji OBJ: 1 ji ji ji
TOP: NBDHE, 6.0. Pharmacology
j i ji ji
2. Which of the following statements is t e regarding planning appointments?
ji ji ji ji ji ji ji ji ji ji
a. Whether or not patients are taking medication for systemic diseases is of little
ji ji ji ji ji ji ji ji ji ji ji ji
consequence in the dental office. ji ji ji ji
b. Asthmatic patients should have dental appointments in the morning. ji ji ji ji ji ji ji ji
c. Diabetic patients usually have fewer problems with a morning appointment com
ji ji ji ji ji ji ji ji ji ji
pared with afternoon appointments. ji ji ji
d. Both B and C are t e. ji ji ji ji ji ji
ANS: D j i
Asthmatic patients who experience dental anxiety should schedule their appointments when they are not
ji ji ji ji ji ji ji ji ji ji ji ji ji jij
shed or under pressure early in the morning. Diabetic patients usually have relatively fewer problems wi
i ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji
th a morning appointment. Patients taking medication for systemic diseases may require special handlin
ji ji ji ji ji ji ji ji ji ji ji ji ji
g in the dental office.
ji ji ji ji
DIF: Comprehension
REF: Role of the Dental Hygienist (Appointment Scheduling) | p. 3
j i ji ji ji ji ji ji ji ji ji ji
OBJ: 1 TOP: NBDHE, 6.0. Pharmacology
j i j i ji ji
,3. Nutritional or herbal supplements ji ji ji
a. carry the U.S. Food and D g Administration (FDA) approval for disease states.
ji ji ji ji ji ji ji ji ji ji ji ji
b. are not d gs. ji ji ji
c. can cause adverse effects. ji ji ji
d. will not interact with other d gs the patient may be taking.
ji ji ji ji ji ji ji ji ji ji ji
ANS: C j i
Nutritional or herbal supplements are quite capable of causing adverse effects. The majority of nutritional
ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji
or herbal supplements do not carry FDA approval for treating disease states. These supplements are d gs a
ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji
nd can cause adverse effects and interact with different d gs.
ji ji ji ji ji ji ji ji ji ji
DIF: Comprehension
REF: Role of the Dental Hygienist (Nutritional or Herbal Supplements) | p. 3
j i ji ji ji ji ji ji ji ji ji ji ji ji
OBJ: 1 TOP: NBDHE, 6.0. Pharmacology
j i j i ji ji
4. Which type of d g name usually begins with a lowercase letter?
ji ji ji ji ji ji ji ji ji ji ji
a. Brand name ji
b. Code name ji
c. Generic name ji
d. Trade name ji
ANS: C j i
Before any d g is marketed, it is given a generic name that becomes the ―official‖ name of the d g. Each d
ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji
g is assigned only one generic name selected by the U.S. Adopted Name Council, and the name is not ca
ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji
pitalized. The brand name is equivalent to the trade name and is capitalized. Although the brand name is
ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji
technically the name of the company marketing the product, this term is often used interchangeably with
ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji
the trade name. The code name is the initial term used within a pharmaceutical company to refer to a d g
ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji
while it is undergoing investigation and is often a combination of capital letters and numbers, the letters
ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji
representing an abbreviation of the company name. ji ji ji ji ji ji
DIF: Comprehension
REF: D g Names | p. 4 OBJ: 3 j i ji ji ji ji ji ji j i
TOP: NBDHE, 6.0. Pharmacology j i ji ji
5. A d g’s generic name is selected by the
ji ji ji ji ji ji ji ji
a. pharmaceutical company manufacturing it. ji ji ji
b. Food and D g Administration (FDA). ji ji ji ji ji
c. U.S. Adopted Name Council. ji ji ji
d. Federal Patent Office. ji ji
ANS: C j i
Each d g is assigned only one generic name (e.g., ibuprofen). It is selected by the U.S. Adopted Name C
ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji
ouncil. The generic name is not selected by the FDA or the Federal Patent Office. The pharmaceutical c
ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji
ompany manufacturing the d g clearly has an influence on the generic name given its d g, but the final dec
ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji
ision is not the company’s.
ji ji ji ji
DIF: Recall REF: D g Names | p. 4 j i ji ji ji ji ji
OBJ: 3 TOP: NBDHE, 6.0. Pharmacology j i ji j i ji ji
6. Which of the following is t e concerning generic and trade names of d gs?
ji ji ji ji ji ji ji ji ji ji ji ji ji ji
a. A d g may only have one generic name and one trade name.
ji ji ji ji ji ji ji ji ji ji ji ji
, b. A d g may only have one generic name, but it may have several trade names.
ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji
c. A d g may have several generic names, but it may only have one trade name.
ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji
d. A d g may have several generic names and several trade names.
ji ji ji ji ji ji ji ji ji ji ji
ANS: B j i
Each d g has only one generic name but may have several trade names. For each d g, there is only one ge
ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji
neric name. It is not capitalized, and it becomes the ―official‖ name of the d g. The pharmaceutical comp
ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji
any discovering the d g gives the d g a trade name. The trade name is protected by the Federal Patent Law
ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji j
for 20 years from the earliest claimed filing date, plus patent term extensions. Although the brand name i
i ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji
s technically the name of the company marketing the product, it is often used interchangeably with the tra
ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji
de name. ji
DIF: Comprehension
REF: D g Names | p. 4 OBJ: 3 j i ji ji ji ji ji ji j i
TOP: NBDHE, 6.0. Pharmacology j i ji ji
7. Two d gs that are found to be chemically equivalent, but not biologically equivalent or ther
ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji
apeutically equivalent are said to differ in ji ji ji ji ji ji
a. potency.
b. efficacy.
c. bioavailability.
d. therapeutic index. ji
ANS: C j i
A preparation can be chemically equivalent yet not biologically or therapeutically equivalent. These pro
ji ji ji ji ji ji ji ji ji ji ji ji ji
ducts are said to differ in their bioavailability. The potency of a d g is a function of the amount of d g requi
ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji
red to produce an effect. The efficacy is the maximum intensity of effect or response that can be produce
ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji
d by a d g. The therapeutic index is the ratio of the lethal dose for 50% of the experimental animals divid
ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji
ed by the effective dose for 50% of the experimental animals. If the value of the therapeutic index is sma
ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji
ll, toxicity is more likely.
ji ji ji ji
DIF: Recall
REF: D g Names (D g Substitution) | p. 5 OBJ: 4
j i ji ji ji ji ji ji ji ji ji j i
TOP: NBDHE, 6.0. Pharmacology j i ji ji
8. How many years must pass after a d g patent expires before other d g companies can market the same
ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji
compound as a generic d g? ji ji ji ji ji
a. 20 years ji
b. 17 years ji
c. 7 years ji
d. 0 years ji
ANS: D j i
Once a d g patent expires, competing companies may immediately market the same compound in generi
ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji
c form. The pharmaceutical company discovering the d g gives the d g a trade name. The trade name is pr
ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji
otected by the Federal Patent Law for 20 years from the earliest claimed filing date, plus the patent term e
ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji ji
xtensions.
DIF: Application
REF: D g Names (D g Substitution) | p. 5 OBJ: 4
j i ji ji ji ji ji ji ji ji ji j i
TOP: NBDHE, 6.0. Pharmacology j i ji ji
